Jan Šperl

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Homie Razavi, Imam Waked, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2014 · 484 citations · Full text

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

Stefan Zeuzem, Peter Ferenci, Jan Šperl et al. · Journal of Hepatology · 2005 · 463 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +10

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Rajeshwar P. Mookerjee, Marco Pavesi, Karen Louise Thomsen et al. · Journal of Hepatology · 2015 · 239 citations · Full text

Inflammation, Liver Fibrosis, Hepatology +15

Strategies to manage hepatitis<scp>C</scp>virus (<scp>HCV</scp>) disease burden

Heiner Wedemeyer, A.‐S. Duberg, Marı́a Buti et al. · Journal of Viral Hepatitis · 2014 · 181 citations · Full text

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 146 citations · Full text

Vaccination, Hcv Infection, Viral Hepatitis +7